Blog

 

Blog

Hogan Lovells Brexit Taskforce responds to Theresa May's speech

5 March 2018

London, 2 March 2018 — Theresa May has today set out in more detail than ever before the bold future relationship that the UK Government believes to be in the interests of both the UK and the EU.  She tackles head on the accusation that any bespoke deal amounts to cherry-picking, recognising that there needs to be a fair balance between benefits and obligations.  She accepts in terms that, where the EU or UK choose to move away from regulatory alignment, that will come with consequent losses in access to each other's markets.

Read more

Jurisdictions: United Kingdom

Blog

Theresa May issues invitation to Brexit economic pragmatism

2 March 2018

By Charles Brasted and Andrew Eaton

On 2 March 2018, Theresa May made her third major speech on Brexit in which she set out in more detail than ever before the ambitious future relationship that the UK Government is seeking to negotiate with the EU. 

Read more

Jurisdictions: United Kingdom

Blog

European Commission publishes guidance on Brexit and UK food exports

6 February 2018

By Julia Fraser and Richard Welfare

On 1 February 2018, the European Commission issued a notice on the impact of Brexit for food products originating from the UK. The Commission confirmed that, in the absence of a transitional agreement, the UK will become a 'third country' from the date of its withdrawal from the EU.

Read more

Jurisdictions: United Kingdom
Services: Food Law

Blog

House of Lords Committee deems Government's Brexit Withdrawal Bill "constitutionally unacceptable"

30 January 2018

By Charles Brasted and Andrew Eaton

On the eve of the debate in the House of Lords on the European Union (Withdrawal) Bill (the Bill), the House of Lords Constitution Committee (the Committee) has published a report (the Report) describing the Bill as "constitutionally unacceptable", "conceptually flawed" and concluding that, in its current form, it "risks fundamentally undermining legal certainty".  The Report calls for a major re-write of the Bill, despite it having already been voted through the House of Commons earlier in January.

Read more

Jurisdictions: United Kingdom

Blog

MHRA confirms UK stance in Brexit update to pharma industry

18 January 2018

By Helen Kimberley and Julia Fraser

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published an update to pharmaceutical companies in the UK on the status of the Brexit negotiations and confirmed the UK's wish for there to be a transition period to allow for a smooth withdrawal. The update, published on 16 January 2018, also sets out the MHRA's expectations for continued involvement in EU affairs during the negotiation period, while the UK remains part of the EU, and clarifies the MHRA's intended approach should a transition or implementation period not be concluded with the EU by March 2019.

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: United Kingdom